Literature DB >> 23637228

Sumoylation of the basic helix-loop-helix transcription factor sharp-1 regulates recruitment of the histone methyltransferase G9a and function in myogenesis.

Yaju Wang1, Shilpa Rani Shankar, Devaki Kher, Belinda Mei Tze Ling, Reshma Taneja.   

Abstract

Sumoylation is an important post-translational modification that alters the activity of many transcription factors. However, the mechanisms that link sumoylation to alterations in chromatin structure, which culminate in tissue specific gene expression, are not fully understood. In this study, we demonstrate that SUMO modification of the transcription factor Sharp-1 is required for its full transcriptional repression activity and function as an inhibitor of skeletal muscle differentiation. Sharp-1 is modified by sumoylation at two conserved lysine residues 240 and 255. Mutation of these SUMO acceptor sites in Sharp-1 does not impact its subcellular localization but attenuates its ability to act as a transcriptional repressor and inhibit myogenic differentiation. Consistently, co-expression of the SUMO protease SENP1 with wild type Sharp-1 abrogates Sharp-1-dependent inhibition of myogenesis. Interestingly, sumoylation acts as a signal for recruitment of the co-repressor G9a. Thus, enrichment of G9a, and histone H3 lysine 9 dimethylation (H3K9me2), a signature of G9a activity, is dramatically reduced at muscle promoters in cells expressing sumoylation-defective Sharp-1. Our findings demonstrate how sumoylation of Sharp-1 exerts an impact on chromatin structure and transcriptional repression of muscle gene expression through recruitment of G9a.

Entities:  

Keywords:  Chromatin Modification; Differentiation; Epigenetics; Helix-Loop-Helix Transcription Factors; Histone Methylation; Myogenesis; Skeletal Muscle; Sumoylation; Transcription Factors

Mesh:

Substances:

Year:  2013        PMID: 23637228      PMCID: PMC3682566          DOI: 10.1074/jbc.M113.463257

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Molecular cloning and characterization of DEC2, a new member of basic helix-loop-helix proteins.

Authors:  K Fujimoto; M Shen; M Noshiro; K Matsubara; S Shingu; K Honda; E Yoshida; K Suardita; Y Matsuda; Y Kato
Journal:  Biochem Biophys Res Commun       Date:  2001-01-12       Impact factor: 3.575

2.  PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases.

Authors:  Noora Kotaja; Ulla Karvonen; Olli A Jänne; Jorma J Palvimo
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

Review 3.  Protein modification by SUMO.

Authors:  Erica S Johnson
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

Review 4.  SUMO and transcriptional regulation.

Authors:  David W H Girdwood; Michael H Tatham; Ronald T Hay
Journal:  Semin Cell Dev Biol       Date:  2004-04       Impact factor: 7.727

5.  Lysine methyltransferase G9a methylates the transcription factor MyoD and regulates skeletal muscle differentiation.

Authors:  Belinda Mei Tze Ling; Narendra Bharathy; Teng-Kai Chung; Wai Kay Kok; SiDe Li; Yong Hua Tan; Vinay Kumar Rao; Suma Gopinadhan; Vittorio Sartorelli; Martin J Walsh; Reshma Taneja
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-03       Impact factor: 11.205

Review 6.  Something about SUMO inhibits transcription.

Authors:  Grace Gill
Journal:  Curr Opin Genet Dev       Date:  2005-10       Impact factor: 5.578

Review 7.  Concepts in sumoylation: a decade on.

Authors:  Ruth Geiss-Friedlander; Frauke Melchior
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

8.  SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins.

Authors:  Michael P Malakhov; Michael R Mattern; Oxana A Malakhova; Mark Drinker; Stephen D Weeks; Tauseef R Butt
Journal:  J Struct Funct Genomics       Date:  2004

9.  Abundant expression of Dec1/stra13/sharp2 in colon carcinoma: its antagonizing role in serum deprivation-induced apoptosis and selective inhibition of procaspase activation.

Authors:  Yuxin Li; He Zhang; Mingxing Xie; Maowen Hu; Shujun Ge; Dongfang Yang; Yinsheng Wan; Bingfang Yan
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

10.  SUMO modification of Stra13 is required for repression of cyclin D1 expression and cellular growth arrest.

Authors:  Yaju Wang; Vinay Kumar Rao; Wai Kay Kok; Dijendra Nath Roy; Sumita Sethi; Belinda Mei Tze Ling; Martin Beng Huat Lee; Reshma Taneja
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

View more
  12 in total

Review 1.  Bone muscle crosstalk targets muscle regeneration pathway regulated by core circadian transcriptional repressors DEC1 and DEC2.

Authors:  Jeffrey P Gorski; Jeffrey L Price
Journal:  Bonekey Rep       Date:  2016-11-16

Review 2.  Understanding the significance of biological clock and its impact on cancer incidence.

Authors:  Shalie Malik; James Stokes Iii; Upender Manne; Rajesh Singh; Manoj K Mishra
Journal:  Cancer Lett       Date:  2021-12-11       Impact factor: 8.679

3.  Small ubiquitin-like modifier (SUMO) protein-specific protease 1 de-SUMOylates Sharp-1 protein and controls adipocyte differentiation.

Authors:  Bingting Liu; Tianshi Wang; Wenhan Mei; Dongdong Li; Rong Cai; Yong Zuo; Jinke Cheng
Journal:  J Biol Chem       Date:  2014-06-18       Impact factor: 5.157

Review 4.  Chromatin signaling in muscle stem cells: interpreting the regenerative microenvironment.

Authors:  Arianna Brancaccio; Daniela Palacios
Journal:  Front Aging Neurosci       Date:  2015-04-07       Impact factor: 5.750

5.  The lysine methyltransferase Ehmt2/G9a is dispensable for skeletal muscle development and regeneration.

Authors:  Regan-Heng Zhang; Robert N Judson; David Y Liu; Jürgen Kast; Fabio M V Rossi
Journal:  Skelet Muscle       Date:  2016-05-27       Impact factor: 4.912

Review 6.  Regulation of transcription factors by sumoylation.

Authors:  Emanuel Rosonina; Akhi Akhter; Yimo Dou; John Babu; Veroni S Sri Theivakadadcham
Journal:  Transcription       Date:  2017-04-05

7.  SUMOylation of G9a regulates its function as an activator of myoblast proliferation.

Authors:  Shruti Srinivasan; Shilpa Rani Shankar; Yaju Wang; Reshma Taneja
Journal:  Cell Death Dis       Date:  2019-03-13       Impact factor: 8.469

Review 8.  DEC1 and DEC2 Crosstalk between Circadian Rhythm and Tumor Progression.

Authors:  Fuyuki Sato; Ujjal K Bhawal; Tomohiro Yoshimura; Yasuteru Muragaki
Journal:  J Cancer       Date:  2016-01-01       Impact factor: 4.207

9.  Small ubiquitin-related modifier 2/3 interacts with p65 and stabilizes it in the cytoplasm in HBV-associated hepatocellular carcinoma.

Authors:  Jun Liu; Manqi Sha; Qianfeng Wang; Yong Ma; Xiaoping Geng; Yufeng Gao; Lijie Feng; Yujun Shen; Yuxian Shen
Journal:  BMC Cancer       Date:  2015-10-12       Impact factor: 4.430

10.  The basic helix-loop-helix transcription factor SHARP1 is an oncogenic driver in MLL-AF6 acute myelogenous leukemia.

Authors:  Akihiko Numata; Hui Si Kwok; Akira Kawasaki; Jia Li; Qi-Ling Zhou; Jon Kerry; Touati Benoukraf; Deepak Bararia; Feng Li; Erica Ballabio; Marta Tapia; Aniruddha J Deshpande; Robert S Welner; Ruud Delwel; Henry Yang; Thomas A Milne; Reshma Taneja; Daniel G Tenen
Journal:  Nat Commun       Date:  2018-04-24       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.